Observed Signal · Oct 14, 2026 · Policy Update · Source: PR Newswire: Advertising & Marketing · Impact: 3/5 · Sentiment: Negative
Hims & Hers Securities Class Action Deadline Nov 2, 2026
Robbins Geller Rudman & Dowd LLP announces a securities class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) for alleged violations of the Securities Exchange Act. Investors who purchased securities between August 4, 2025 and July 29, 2026 have until November 2, 2026 to seek lead plaintiff appointment. The lawsuit follows an FTC complaint alleging Hims & Hers shared sensitive health information with third-party advertising platforms like Meta and Snap, and misled consumers about billing. The stock dropped nearly 15% upon the FTC news. Lead plaintiff process outlined under the Private Securities Litigation Reform Act.
High relevance to AdTech due to FTC action and allegations of improper data sharing with ad platforms, impacting trust and regulatory compliance in health data advertising.
Track Hims & Hers Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- FTC filed a lawsuit against Hims & Hers on July 29, 2026, alleging sharing of sensitive health data with advertising platforms.
- Hims & Hers stock declined nearly 15% following the FTC announcement.
- Robbins Geller Rudman & Dowd LLP filed a class action lawsuit (Velanki v. Hims & Hers Health, Inc.) in the Northern District of California.
- Investors have until November 2, 2026 to seek lead plaintiff appointment.
- The lawsuit alleges false statements and failure to disclose regulatory scrutiny and potential penalties.
Connected Companies & Entities
4 Entities mapped“The class action lawsuit charges Hims & Hers and certain of its top executives with violations of the Securities Exchange Act of 1934.”
“the Federal Trade Commission's complaint ... shared consumers' sensitive health information with third-party advertising companies and platf...”
“shared consumers' sensitive health information with third-party advertising companies and platforms . . . such as ... Snap Inc. ('Snap')”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Hims & Hers Securities Fraud Class Action Filed
A securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) in the U.S. District Court for the Northern District of California. The suit alleges the telehealth company disclosed sensitive health information to third-party advertising platforms, including Snap and Meta (Facebook), without proper consent, and misled consumers about billing practices. The FTC filed a related lawsuit on July 29, 2026, causing the stock to drop 14.73% to $25.00. Investors who purchased HIMS securities between August 4, 2025, and July 29, 2026, have until November 2, 2026, to apply as lead plaintiff. The case, Velanki v. Hims & Hers Health, Inc. et al., is being publicized by law firms including Kahn Swick & Foti, Kessler Topaz Meltzer & Check, and the Law Offices of Howard G. Smith.
FTC sues Hims & Hers over sharing health data
The U.S. Federal Trade Commission has sued telehealth and consumer healthcare company Hims & Hers, alleging the company shared customers’ sensitive medical and healthcare information with advertisers and major tech firms including Meta and Snap, and misled consumers about its privacy practices. The FTC's complaint, filed in a California federal court, says Hims & Hers placed pixel-sized trackers from Meta, Snap, Microsoft, Pinterest, Reddit and X that captured and shared users’ health information. The complaint also accuses the company of deceptive billing practices and creating barriers to cancellation. Hims & Hers responded that its privacy policy enables users to choose how their data is used and said it will defend against the allegations. The action continues a pattern of FTC enforcement against healthcare-related companies over third-party web trackers.
HYLN Investors Can Lead Securities Fraud Lawsuit
Rosen Law Firm reminds investors who purchased Hyliion Holdings Corp. (NYSE American: HYLN) securities between May 12, 2026 and June 23, 2026 of the October 27, 2026 lead plaintiff deadline. The class action lawsuit alleges that Hyliion made false or misleading statements about its commercial pipeline, particularly regarding its VFG Holdings partnership and the evaluation of VFG's operational and financial capabilities before announcing the 'new data center partnership'. When the true details emerged, investors suffered damages. Investors may be entitled to compensation through a contingency fee arrangement. To join the class action, visit rosenlegal.com or contact Phillip Kim, Esq.
Receive all future signals for Hims & Hers & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.